{"id":36374,"date":"2013-05-09T08:00:42","date_gmt":"2013-05-09T12:00:42","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=voices&#038;p=36374"},"modified":"2013-05-08T12:45:32","modified_gmt":"2013-05-08T16:45:32","slug":"journal-x-not-so-subtle-marketing-messages","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2013\/05\/09\/journal-x-not-so-subtle-marketing-messages\/","title":{"rendered":"Journal X: Not so Subtle Marketing Messages"},"content":{"rendered":"<p>I was the rare resident who thought that conflict of interest issues in medicine were a bit overblown. I did not find (or ignored) the evidence that pharma\u00a0played a role in prescribing habits very persuasive, at least not when it came to my personal prescribing habits. I was not alone among the house staff, however, \u00a0in appreciating an occasional &#8220;free&#8221; lunch, and the much rarer sponsored\u00a0dinners at places I couldn&#8217;t afford as a physician-in-training.<\/p>\n<p>Now I&#8217;m a fellow, and my attitudes about the pervasiveness of pharma influence have changed. Am I older and wiser? I&#8217;d like to think so. But I owe most of my conversion to the fresh perspective of my three-year-old daughter. She refers to most things by their color, including a majority of my medical journals. For instance, my <em>JACC<\/em> journals: blue for the mother journal, red for heart failure, green for interventions, etc. But then she started calling the original <em>JACC<\/em> the &#8220;X&#8221; journal. When I asked her why, she pointed to the &#8220;X&#8221; in\u00a0Xarelto\u00a0(rivaroxaban). I realized that every issue of\u00a0<em>JACC<\/em>\u00a0is covered front to back with the &#8220;X&#8221;. The message was subliminal to me, but quite obvious to her.<\/p>\n<p><strong>How do you think all of our pharma marketing looks with naive eyes?<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>My 3-year-old daughter helps me see the influence of pharma on research.<\/p>\n","protected":false},"author":328,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1446,201,1407],"class_list":["post-36374","post","type-post","status-publish","format-standard","hentry","category-general","tag-advertising","tag-conflict-of-interest","tag-pharmaceutical-industry"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/36374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/328"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=36374"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/36374\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=36374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=36374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=36374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}